|
|
The Latin America Congress on
Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy)
Hilton Hotel, Buenos Aires, Argentina, March 11-14, 2010 |
|
| |
| Program Table |
 |
|
|
08:30-10:30 |
|
|
Plenary Session 1
08:30-08:45: Opening Remarks
L.E. Litwak, I. Raz
EVIDENCE FROM THE LAST CLINICAL TRIALS IN DIABETES
Chairpersons: S. Cavalcanti, B.L. Wajchenberg
What should we learn from the main prospective trials in diabetes?
P. Home
Should we diagnose diabetes by A1C only?
Pro: P. Aschner
Con: R.A. deFronzo
PANEL DISCUSSION
G. Fuente, F. Lavalle
|
|
|
|
|
|
|
10:50-12:30 |
|
|
Session 2
ALAD/WORLDWIDE DIABETIC POLYNEUROPATHY, TREATMENT AND DIAGNOSE GUIDELINES
Chairpersons: J. Davidson, J. Rosas Guzmán
Diabetic Polyneuropathy: Current concepts in Latin America
J. Rosas Guzmán
Epidemiology and statistics
H.C. Pedrosa
Physiopathology and diagnose
A. Odriozola
PANEL DISCUSSION
Treatment guidelines
A. Odriozola
Closing remarks
|
Session 5A
INCRETINS BASED THERAPY
Chairperson: J. Rosenstock
Enteroinsular axis in type 2 diabetes: from pathophysiology to therapeutics
S. Kahn
GLP-1 analogues and DPP-4 inhibitors. Clinical pharmacology
J. Rosenstock
Role of incretin based therapies according to the newest treatment algorhythms
S. Del Prato
PANEL DISCUSSION
S. Del Prato, S. Kahn, J. Rosenstock |
Session 6
Chairpersons: P. Home, P. Orduñez-Garcia
VASCULAR DAMAGE IN DIABETES AND HYPERTENSION
Vasculature in obesity, diabetes and hypertension
D. Marante
Microcirculation window to glomerulus
L. Raij
Hemorheologic factors in DM
R. Lyra
PANEL DISCUSSION
P. Home, R. Lyra, D. Marante, L. Raij, P. Orduñez-Garcia
|
|
|
|
|
|
|
13:10-14:00 |
|
|
Session 3
MEET THE PROFESSOR
Self and continuous monitoring in T2DM patients
Coordinator: J. Davidson
Professor: V. Commendatore |
Session 7
MEET THE PROFESSOR
Should physicians measure BMI or waist circumference in clinical practice?
Coordinator: S. Schraier
Professor: S. Klein
|
Session 10
MEET THE PROFESSOR
The Metabolic Syndrome: Insulin resistance in disguise
Coordinator: M. Bendersky
Professor: R.A. DeFronzo
|
|
|
|
14:10-15:40 |
|
|
WHICH IS THE MOST IMPORTANT CARDIOVASCULAR RISK IN DIABETES?
Chairpersons: M. de Sereday, J. Wainstein
Lipoprotein disorders
R. Carmena
Shift in blood pressure management
M. Bendersky
Metabolic disturbances: Hyperglycaemia and obesity
S. Klein
PANEL DISCUSSION
M. de Sereday, Argentina J. Wainstein, Israel R. Carmena, Spain M. Bendersky, Argentina S. Klein, USA |
Session 8
14:20-15:00
Chairperson: J.A. Mesa Pérez
CONFERENCE OF LATINOAMERICAN ASSOCIATION OF DIABETES (ALAD) TREATMENT OF T2D
Consensus of Latinamerican societies of diabetes and endocrinology
J. Rosas Guzmán
15:00-16:00
ORAL PRESENTATIONS
Please see the Congress Program
|
Session 11
CAUSE OF HYPERTENSION
Chairperson: R. Rey
Role of autonomic system
A. Ramirez
Role of angiotensin-renin system
G. Waisman
PANEL DISCUSSION
A. Ramírez, R. Rey, G. Waisman
|
|
|
|
|
|
|
16:00-17:30 |
|
|
Session 5
DIFFERENT PHENOTYPES OF DIABETES
Chairperson: G. Frechtel
LADA: combination of type 1 and type 2 diabetes
P. Pozzilli
Type 2 diabetes in the young
I. Libman
Type 1 diabetes plus metabolic syndrome
I. D. Escobar
PANEL DISCUSSION
I. D. Escobar, G. Frechtel, I. Libman, P. Pozzilli |
Session 9
ORAL PRESENTATIONS
Chairperson: J. Mestman
Novel Mechanisms for the
Treatment of T2DM
H.L. Katzeff
Long-acting weekly GLP-1 receptor agonists: How far have we gone?
J. Rosenstock
Alternative route for insulin therapy
P. Raskin
PANEL DISCUSSION
H.L. Katzeff, J. Mestman, P. Raskin, J. Rosenstock
|
Session 12
INSULIN THERAPY
Chairperson: G. Fuente
The issue of intensive diabetes treatment in hospitals
D. Marante
Intensification of insulin treatment in T2D
I. Raz
Safety of modern insulin
D. Russell-Jones
PANEL DISCUSSION
G. Fuente, D. Marante, D. Russell-Jones
|
|
|
08:45-10:30 |
|
|
Session 13
T2D-FIRST LINE OF THERAPY?
Chairpersons: M. García de los Rios, B. Itzhak
Combination of two agents
Combination therapy: S. Del Prato
Monotherapy: P. Home
Secretagos; Which one?
M. Vinocour
PANEL DISCUSSION
C. Belzarena, M. García de los Rios, C. Musso |
Session 18
OBESITY AND METABOLIC SYNDROME
Chairpersons: S. Kahn, M. Katz
Diet, exercise or both?
Diet: D. Marrero
Excercise: M. Rodriguez
Is there light in the future for new pharmalogical agents?
S. Klein
Structural and functional disorders of the thyroid and their relationship to diabetes, obesity and insulin resistance
J. Garber |
Session 23
NEW HORIZONS IN THE TREATMENT OF T2D
Chairpersons: O. Minuchin, C.E. Zubiate Lopez
Early insulin therapy in type 2 diabetic patients
Pro: A. Chacra
Con: L. Litwak
TZD dead or alive?
Pro:I. Sinay
Con: P. Aschner
PANEL DISCUSSION
A. Chacra , D. Marante, M.V. Vinocour Fornieri |
|
|
|
|
|
|
10:50-12:30 |
|
|
Session 14
GLP-1 RECEPTOR AGONISTS AND DPP-4 INHIBITORS. A CLINICAL COMPARISON
Chairperson: H.C. Pedrosa
Glycaemic control
S. Kahn
Impact on non glycaemic effect
J. Rosas Guzmán
Potential to reduce CV risk
R. D. Santos
PANEL DISCUSSION
P. Arias, F. Lavalle, R. Lyra, C. Zubiate Lopez
|
Session 19
LIPIDS IN DIABETES
Chairperson: C. Rondinone
Metabolic consequences of lipotoxicity in obesity: Prevention and treatment
K. Cusi
The expandability hypothesis and diabetes: What does it have to do with liver, muscle and pancreatic fat?
A. Godoy-Matos
Prevention of T2DM: To treat or not to treat?
Treat: A. Halpern
Do not treat: K. Cusi
|
Session 24
NOVEL TREATMENTS IN DIABETIC PATIENTS WITH HYPERTENSION
Chairperson: M.V. Vinocour Fornieri
NOVEL TREATMENTS IN DIABETIC PATIENTS WITH HYPERTENSION
Antihypertensive treatment in “normotensive diabetic patient”
Pro: M. Bendersky
Con: A. Ramírez
The positive side of future treatments
D. Marante
PANEL DISCUSSION
M. Bendersky, D. Marante, A. Ram rez, M.V. Vinocour Fornieri
|
|
|
|
|
|
|
13:10-14:00 |
|
|
Session 15
MEET THE PROFESSOR
Post meal glucose variability: Does it make a difference in prediabetes or diabetes?
Coordinator: M. Escalante
Professor: J. Tuomilehto
|
Session 20
MEET THE PROFESSOR
Nonalcoholic fatty liver disease (NAFLO): Fact or fiction?
Coordinator: I. Raz
Professor: K. Cusi
|
Session 25
MEET THE PROFESSOR
Chairperson: J.F. Navarro-González
The use of diurectics in the treatments of blood pressure in patients with T2D
Pro: P.M. Nilsson
Con:L. Raij
|
|
|
|
14:10-15:40 |
|
|
Session 16
TREATMENT TARGET: SHOULD WE TARGET ON BETA CELL ONLY?
Chairperson: J. Mestman
Beta cell: J.J. Gagliardino
Alpha cell, muscle, liver and episode tissue
R.A. DeFronzo
PANEL DISCUSSION
P. Aschner, J. Rosas Guzmán, M.A. Tambascia |
Session 21
TREATMENTS OF T2D
Chairperson: S. Gutt
Bariatric surgery as a treatment for diabetes and obesity
Pro: A. Halpern
Con: S. Klein
PANEL DISCUSSION
A. Chacra, A. Godoy-Matos, M. Katz, S. Schraier |
Session 26
DIABETIC NEPHROPATHY BEYOND RAS INHIBITOR
Chairperson: J. Garber
Calcium channel blockers/ diuretics
L. Raij
Double or triple RAS blocked
Blockade of inflammatory pathways
J.F. Navarro-Gonzalez
PANEL DISCUSSION
J. Garber, R. Lyra, J.F. Navarro-Gonzalez, A. Villamil |
|
|
|
|
|
|
16:00-17:30 |
|
|
Session 17
Chairperson: H.C. Pedrosa
DIABETIC FOOT: INTERDISCIPLINARY INTERVENTION
Vascular surgeon
A.C. de Souza
Orthopedic intervention
M. Carrasco
Cost of the diabetic foot
A. Odriozola
PANEL DISCUSSION
M. Carrasco, A.C. de Souza, M. Escalante, H.C. Pedrosa |
Session 22
Chairperson: P.M. Nilsson
SMOKING CESSATION - GET READY FOR SUCCESS!
Evolutionary perspectives on addiction leading to smoking, obesity and drug abuse
P.M. Nilsson
Smoking. Global epidemic smoking cessation strategies The evidence
V. Schoj
Non-pharmacological support and counseling
P. Tønnesen
Drug treatment
P.M. Nilsson
PANEL DISCUSSION
P.M. Nilsson, V. Schoj, P. Tønnesen |
Session 27
Chairperson: M.A. Tambascia
TREATMENT GOALS IN DIABETES
Near normal HbA1c in T2DM?
Pro: S. Del Prato
Con: J. Davidson
How low is low in blood pressure control in patients with diabetes?
R. Carmena
PANEL DISCUSSION
R. Carmena, S. Del Prato, M.A. Tambascia |
|
|
08:45-10:30 |
|
Session 27
HAPO STUDY
Chairperson: Z. Shoham
Results of the Hyperglycemia & Adverse Pregnancy Outcome (HAPO) Study: Implications for Clinical Practice
B. Metzger
Insulin
C. Faingold
Non-Insulin intervention
Maternal hyperglycaemia: Long term effect on offspring
J. Mestman
PANEL DISCUSSION
G. Lopez, J. Mestman, Z. Shoham
|
Session 29
TREATMENT OF DIABETIC DISLYPIDIMIA
Chairperson: P. Aschner The aim of lipid lowering therapy in people with diabetes
P. Aschner
Diabetic dyslipidemia: statin vs. combination therapy
Statin:I.Raz
Combination therapy: J. Wainstein
PANEL DISCUSSION
P. Aschner, I.Raz, J. Wainstein |
|
|
|
|
|
|
|
10:50-12:30 |
|
|
Session 30
Plenary Session
Chair: J. Montero
EVIDENCE BASE DATA OF CLINICAL TRIALS ON WEIGHT LOSS
Diabetes prevention lessons from the Diabetes Prevention Program (DPP)
D. Marrero
Adipose tissue and inflammation
B.L. Wajchenberg
Effects of weight loss on metabolic health
S. Klein
12:20-12:30: Closing Remarks
J. Davidson , L.E. Litwak, J. Mestman
|
|
|
|
|
|
|
English
Español
WebStudio.co.il